In:
Cancer, Wiley, Vol. 116, No. 10 ( 2010-05-15), p. 2301-2306
Kurzfassung:
The combination of uracil and ftorafur (UFT) and leucovorin administered orally in a twice‐daily regimen is reported to have modest activity in patients with metastatic breast cancer who had been previously treated with anthracyclines and/or taxanes. Grade 3 toxicities were found to be manageable with appropriate dose adjustments.
Materialart:
Online-Ressource
ISSN:
0008-543X
,
1097-0142
DOI:
10.1002/cncr.v116:10
Sprache:
Englisch
Verlag:
Wiley
Publikationsdatum:
2010
ZDB Id:
1479932-7
ZDB Id:
2599218-1
ZDB Id:
2594979-2
ZDB Id:
1429-1